KLF16 suppresses human glioma cell proliferation and tumourigenicity by targeting TFAM.
CONCLUSIONS: KLF16 is a key regulator of glioma cell proliferation by directly targeting TFAM.
PMID: 29374989 [PubMed - as supplied by publisher]
Source: Artificial Cells, Nanomedicine and Biotechnology - Category: Biotechnology Tags: Artif Cells Nanomed Biotechnol Source Type: research
More News: Biotechnology | Brain Tumor | Cancer | Cancer & Oncology | Genetics | Glioma | Nanotechnology | Study | Transplants